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•

Metastases

Statistics
• k

A metastases is a secondary malignant growth
that develops somewhere else in the body as a
result of the primary cancer.

• 40% of cancer patients will develop metastatic
disease of the spine (Gong et al., 2019).

•

A spinal metastases is when cancer from the
original site spreads to the spine or spinal cord.

•

The spine is a common site for metastases.

•

Radioresistant tumors are tumors that are resistant
to the effects of radiation.

•

Spinal metastases such as renal cell, sarcoma,
melanoma, and colorectal are considered
radioresistant, but can now be treated with
Stereotactic Body Radiation Therapy (SBRT).

Stereotactic Body Radiation Therapy
•

SBRT is used in Radiation Therapy to deliver high
does of tightly focused radiation to a tumor in one
or more fractions/ treatments.

• Compared to conventional external beam
Radiation Therapy (cEBRT), patients have
40% more pain relief with SBRT.
• Pain response to SBRT treatment is between
46-92% regardless the number of fractions
given (Zeng et al., 2019).
• One study gathered data from multiple studies
which evaluation local control (LC) and
overall survival (OS) after one year:
• One fraction- 92.7% LC and 53%
OS

SBRT is used for ablative intent and spares dose to
the spinal cord.

• Two fraction- 84.6% LC and
70.4% OS

•

One to five fractions are a typical treatment plan
for patients receiving SBRT.

•

• Three fraction- 86.8% LC and
60.1% OS

Dose varies per fraction but typically follows:

•

1 fraction- 16-24 Gy

•

2-3 fractions- 24-30 Gy

•

4-5 fractions- 30-40 Gy

Patient immobilization, treatment planning,
treatment volume definitions, and image-guidance
are important aspects of SBRT.

Fig. 1 Planned spinal treatment

Procedure
•

•

•

•

The patient is a 53-year-old female with a
history of stage 3A grade 3 invasive ductal
carcinoma of the right breast. She received
radiation and chemotherapy as treatment for the
breast cancer.
In 2021, images revealed progression of
metastatic carcinoma to the thoracic spine at the
level of T10.

•

Stereotactic Body Radiation Therapy was
advised to treat the T10 vertebral body lesion.

•

The treatment plan consisted of 3 treatment
fractions that would be given every other day.

•

900 cGy was given per fraction, with a total
dose of 2700 cGy (27Gy) (Northeast Radiation
Oncology Center, 2022).

Advantages & Disadvantages
Advantages
• The need for surgery is eliminated or
diminished because SBRT safely targets the
metastatic lesions.
• High does eliminate the need for multiple
fractions.

• More positive outcomes compared to
cEBRT.

Disadvantages
• Pain flare is reported in 15-68% of patients.
• Vertebral compression fractures occur in
11-40% of patients.
• Nerve injury occurs in 0.05% of patients.
• Myelopathy is uncommon, however most
feared when the spinal cord dose increases
beyond 13.85 Gy (Balakrishnan et al.
2022).

• Four fraction- 82.6% LC and 48%
OS
• Five fraction- 80.6% LC and 80%
OS
• Other studies have compared pain control for
one fraction of SBRT treatment to 8-10
fractions of cEBRT. Results showed an upward
trend towards complete pain response rates at
3 and almost a complete response to pain relief
at 6 months (Dunne, Liu, Lo, & Sahgal, 2022).

Fig. 2 Spine image
• The image shows the spinal lesion and how the
radiation will intersect through the patient’s body.

Fig. 4 Planned organ at risk volume

Conclusion
Indications & Contraindications

Patient selection is dependent upon certain criteria
that is evaluated by medical and radiation
oncologists, radiologists, and spine surgeons.

• SBRT is indicated for patients with metastases
on the spine or patients with a history of
radioresistant tumors.

A thermoplastic mask or vacuum bag are custom
made for the patient and used as an
immobilization device to ensure the patient is in
the same position for every treatment.

• SBRT is a concern for patients with epidural
extension, spinal cord compression, and
paraspinal compression (Balakrishnan,
Sebastian, & Zaveri, 2022).

A CT or MRI scan is required as well as a cone
beam CT prior to treatment to confirm location.

•

• Over 180,000 spinal metastases are diagnosed
in the United States every year.

•

•

Case Study

• SBRT delivers a precise dose of radiation to
a small tumor on the spine.

Fig. 3 Histogram Image

• The histogram demonstrates how much radiation
each structure next to the spinal lesion is receiving.
• The spinal cord dose was planned to be less than
2190.0 cGy. The actual spinal cord dose was 1826.5
cGy after treatment.

• The entire vertebral body, pedicle, lamina,
transverse process and spinous process are
typically treated.
• Prognosis is generally dependent upon, age,
gender, number of organs involved,
previous treatment to the effected area, and
physical state.
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